SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes

NCT03982381 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2067

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Metformin
DRUG: Dapagliflozin 10 MG

Sponsor

Uppsala University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]